Your browser doesn't support javascript.
loading
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
De Gassart, Aude; Demaria, Olivier; Panes, Rébecca; Zaffalon, Léa; Ryazanov, Alexey G; Gilliet, Michel; Martinon, Fabio.
Affiliation
  • De Gassart A; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
  • Demaria O; Department of Dermatology, CHUV, Lausanne, Switzerland.
  • Panes R; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
  • Zaffalon L; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
  • Ryazanov AG; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers The State University of New Jersey, Piscataway, NJ, USA.
  • Gilliet M; Department of Dermatology, CHUV, Lausanne, Switzerland.
  • Martinon F; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland fabio.martinon@unil.ch.
EMBO Rep ; 17(10): 1471-1484, 2016 10.
Article in En | MEDLINE | ID: mdl-27572820
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Elongation Factor 2 Kinase / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2016 Type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Elongation Factor 2 Kinase / Neoplasms Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: EMBO Rep Journal subject: BIOLOGIA MOLECULAR Year: 2016 Type: Article Affiliation country: Switzerland